Drug Screening Market By Product (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), Sample (Urine, Breath), End-User Industry & Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits - Forecast 2024-2032

Industry : Healthcare | Pages : 180 Pages | Published On : Mar 2024

         
     
The Drug Screening Market is Valued USD 6.6 billion in 2024 and projected to reach USD 27.1 billion by 2032, growing at a CAGR of 16.30% During the Forecast period of 2024-2032.

 

Drug screening is the method employed to detect both illegal and prescribed medications within biological samples such as blood and urine. It serves as a means to uncover the presence of performance-enhancing substances, like steroids and human growth hormone (HGH), utilized by professional athletes to augment their endurance and prowess during competitions. Illicit substances like heroin, cannabis, cocaine, methamphetamines, methadone, and amphetamine are commonly targeted through drug screening procedures. Globally, the escalating prevalence of drug consumption has stirred concern among numerous nations. In 2010, the National Institute on Drug Abuse (NIDA) estimated that approximately 22.6 million individuals in the United States engaged in illegal drug usage, constituting about 8.9% of the total population. The upsurge in alcohol consumption among both younger and older demographics, coupled with the misuse of prescribed medications and the heightened utilization of opioid painkillers and unlawful substances, stands as a primary impetus driving market growth. Correspondingly, the surge in illegal drug consumption and the subsequent increase in crime rates linked to substance dependence are foreseen to fuel the demand for drug screening solutions. Manufacturers are engaging in heightened competition, vying for larger market shares by expanding their product portfolios across various categories.

Concurrently, ongoing technological advancements are anticipated to propel the global drug screening market over the forecast period. However, the growing awareness about the perils of intoxicated driving, coupled with stringent alcohol and drug regulations within corporate and governmental entities, are poised to impose limitations on the expansion of the global drug screening market.

Drug Screening Market Size

Graph
ReportDetails
Market Size ValueUSD 6.6 billion in 2024
Market Size ValueUSD 27.1 billion by 2032
CAGR16.30%
Forecast Period2024-2032
Base Year 2023
Historic Data2020
Segments CoveredProduct, Sample Type, End-user and Region
Geographics CoveredNorth America, Latin America, Europe, Asia-Pacific, Middle East & Africa

Major players in the Drug Screening Market include LabCorp (Laboratory Corporation of America Holdings), Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Alfa Scientific Designs, Inc., OraSure Technologies, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, LifeLoc Technologies, Drägerwerk AG & Co. KGaA, Premier Biotech, Inc., Quidel Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Others.

Growing prevalence of drug abuse and illegal applications of drugs propel the global drug screening market

The rising occurrence of drug misuse and illicit drug utilization drives the expansion of the worldwide drug screening market. The implementation of rigorous regulations governing drug and alcohol testing, coupled with the introduction of fresh and inventive products following regulatory endorsements, propels the pace of growth within this market domain. Escalating apprehensions surrounding workplace safety have rendered routine drug screening tests mandatory. Consequently, the surge in demand for non-intrusive screening devices is generating a global upswing in the drug screening market.

Increasing adoption of advanced technologies for more accurate and efficient drug testing processes

A significant trend within the drug screening market revolved around the heightened adoption of cutting-edge technologies to enhance the precision and efficiency of drug testing procedures. These advanced tools were designed to refine the accuracy of drug detection, mitigate instances of false positives/negatives, and optimize the overall screening process. The field of drug screening was progressively gravitating towards increased automation and the implementation of high-throughput screening systems. This transition encompassed the utilization of robotics, automated liquid handling, and sophisticated software to streamline the screening workflow. This advancement enabled laboratories to handle a larger volume of samples in reduced time frames, proving particularly advantageous for pharmaceutical companies and research institutions tasked with scrutinizing extensive compound libraries to identify potential drug candidates.

North America accounted for a relatively larger revenue share than other regional markets in the global drug screening market in 2022:

The predominant share of revenue in the North American drug screening market can be attributed to the upsurge in drug misuse incidents and the implementation of regulations permitting drug testing across the region. The substantial presence of key market players in this area also contributes significantly to the overall revenue growth. Within this region, the United States holds the largest portion of revenue due to the escalating prevalence of illicit substances within the country. Further driving the expansion of the market in the U.S. is the mounting occurrence of accidents. Capitalizing on the foundation of government-level drug testing initiatives, private sector employers have initiated workplace drug testing programs to assess both potential candidates and existing employees. Quest Diagnostics, a prominent player, conducts over ten million occupational drug tests annually in the U.S. These tests encompass urine, oral fluid, and hair specimens and are supported by a widespread network of specimen collection sites and federally authorized drug testing laboratories.

As for upcoming regions, the Asia-Pacific market is poised for a substantial Compound Annual Growth Rate (CAGR). This trajectory is propelled by escalating requisites for substance abuse screening, particularly in emerging economies such as China and India. The surge in substance misuse challenges, instances of drug-related offenses, and fatal traffic incidents within these nations has led to an augmented demand for drug testing measures. Moreover, the region is witnessing a rapid proliferation of individuals grappling with drug addiction, coupled with advancements in cutting-edge drug and alcohol screening technologies. An increased awareness regarding the significance of alcohol and drug screening, alongside the active involvement of private institutions in bolstering drug detection systems, is projected to exert a significant influence on the expansion of the Asia-Pacific drug screening market.

The Drug Screening Market research report provides an in-depth overview of the industry including market segmentation by Product, Sample Type, End-user, and Region. Analysis of the global market with a special focus on high-growth applications in each vertical and fast-growing market segment. It includes a detailed competitive landscape with identification of the key players concerning each type of market, in-depth market share analysis with individual revenue, market shares, and top players’ rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, and game-changing developments such as new product launches, collaborations, expansions, investment analysis, mergers, and acquisitions. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.

The report further studies the market strategies of key players, recent development status, plans, and Drug Screening Market trends across the world. Also, it splits the market segmentation further to deep dive into research and reveals company profile and prospects.

Major Classifications are as follows:

  • By Product
    • Drug Screening Product
    • Analytical Instruments
      • Breathanalyzers
        • Fuel Cell Breathalyzer
        • Semiconductor Breathalyzer
        • Others
      • Immunoassay Analyzer
      • Chromatography Instruments
    • Rapid Testing Devices
      • Urine Testing Devices
        • Drug Testing Cups
        • Dip Cards
        • Drug Testing Cassetts
    • Oral Fluid Testing Devices
    • Consumables
      • Assay Kits
      • Sample Collection Devices
      • Calibrators & Controls
      • Others
    • Drug Screening Service
  • By Sample Type
    • Urine samples
    • Breath Samples
    • Oral Fluid Samples
    • Hair Samples
    • Others
  • By End-user
    • Drug testing laboratories
    • Drug treatment centers
    • Pain management centers
    • Hospitals
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia Pacific
    • Rest of the World
      • Middle East
        • UAE
        • Saudi Arabia
        • Israel
        • Rest of the Middle East
      • Africa
        • South Africa
        • Rest of the Middle East & Africa

Reason to purchase this Drug Screening Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Drug Screening Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Drug Screening Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Drug Screening Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Drug Screening Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Drug Screening Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
  3. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  4. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
  5. Drug Screening Market, By Product
    1. Introduction
    2. Drug Screening Product
    3. Analytical Instruments
      1. Breathanalyzers
        1. Fuel Cell Breathalyzer
        2. Semiconductor Breathalyzer
        3. Others
      2. Immunoassay Analyzer
      3. Chromatography Instruments
    4. Rapid Testing Devices
      1. Urine Testing Devices
        1. Drug Testing Cups
        2. Dip Cards
        3. Drug Testing Cassetts
    5. Oral Fluid Testing Devices
    6. Consumables
      1. Assay Kits
      2. Sample Collection Devices
      3. Calibrators & Controls
      4. Others
    7. Drug Screening Service
  6. Drug Screening Market, By Sample Type
    1. Introduction
    2. Urine samples
    3. Breath Samples
    4. Oral Fluid Samples
    5. Hair Samples
    6. Others
  7. Drug Screening Market, By End-user 
    1. Introduction
    2. Drug testing laboratories
    3. Drug treatment centers
    4. Pain management centers
    5. Hospitals
    6. Others
  8. Drug Screening Market, By Geography
    1. North America
      1. U.S.
      2. Canada
    2. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Rest of the world (RoW)
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  9. Competitive Landscapes
    1. Introduction
    2. Top Companies Ranking
    3. Market Share Analysis
      1. Competition Dashboard
      2. Market Share Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. LabCorp (Laboratory Corporation of America Holdings)
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Quest Diagnostics
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Abbott Laboratories
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
        6. Rewards & Recognition
      4. Thermo Fisher Scientific, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. Alfa Scientific Designs, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. OraSure Technologies, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. Siemens Healthcare GmbH
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. F. Hoffmann-La Roche Ltd
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. Shimadzu Corporation
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. LifeLoc Technologies
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. Drägerwerk AG & Co. KGaA
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. Premier Biotech, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. Quidel Corporation
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. Bio-Rad Laboratories, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. Agilent Technologies, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com